Cargando…
Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer
BACKGROUND: NSCLC patients with EGFR mutation were at a higher incidence of developing brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM incidence becomes increasingly significant for NSCLC patients to achieve prolonged survival. The aim of the study was to expl...
Autores principales: | Ouyang, Wen, Yu, Jing, Zhou, Yan, Hu, Jing, huang, Zhao, Zhang, Junhong, Xie, Conghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390194/ https://www.ncbi.nlm.nih.gov/pubmed/32723319 http://dx.doi.org/10.1186/s12885-020-07202-8 |
Ejemplares similares
-
Metachronous Brain Metastasis in patients with EGFR-mutant NSCLC indicates a worse prognosis
por: Ouyang, Wen, et al.
Publicado: (2020) -
Risk factors of acquired T790M mutation in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer
por: Ouyang, Wen, et al.
Publicado: (2020) -
Prophylactic cranial irradiation for extensive-stage small cell lung cancer: Analysis based on active brain MRI surveillance
por: Yu, Jing, et al.
Publicado: (2020) -
Stereotactic body radiotherapy improves the survival of patients with oligometastatic non‐small cell lung cancer
por: Ouyang, Wen, et al.
Publicado: (2019) -
Risk factors of brain metastasis during the course of EGFR-TKIs therapy for patients with EGFR-mutated advanced lung adenocarcinoma
por: Ma, Xiaoyan, et al.
Publicado: (2016)